Characteristics of Metabolic Dysfunction-Associated Steatotic Liver Disease and Its Risk for Hepatic Fibrosis in 476,124 Korean Adults: A Cross-Sectional Study
Endocrinology and Metabolism · 31.08.2025 · 40 (4) · 648-652
DOI: 10.3803/enm.2024.2281 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Endocrinology and Metabolism, erschienen am 31.08.2025. Verfasst von Da Yeon Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seou…. Hauptthemen laut MEDLINE: Liver Cirrhosis, Non-alcoholic Fatty Liver Disease, Fatty Liver, Metabolic Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
As the new terminology of metabolic dysfunction-associated steatotic liver disease (MASLD) and MASLD with increased alcohol intake (MetALD) has emerged, the clinical significance of MASLD is increasing. This cross-sectional study analyzed 476,124 health checkup participants (2002–2022) to compare hepatic fibrosis risks across MASLD, MetALD, non-alcoholic fatty liver disease (NAFLD), and metabolic dysfunction-associated fatty liver disease (MAFLD). Steatotic liver was identified via ultrasonography, and fibrosis risk was assessed using aspartate aminotransferase to platelet ratio index and NAFLD fibrosis score. The prevalence of NAFLD, MAFLD, MASLD, and MetALD was 30.1%, 32.3%, 29.8%, and 3.0%, respectively, with a 27.9% overlap among three conditions. Participants with steatotic liver were predominantly male, with higher glucose, lipids, liver enzymes, and homeostasis model assessment of insulin resistance levels. Three disease definitions largely overlapped, with MASLD and NAFLD being very similar, while participants with MAFLD and MetALD showed increased fibrosis risk (clinical trial registration number: 2024-11-050).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Zitieren
APA
Lee, D. Y., Ko, J. H., Jang, H. N., Moon, S. J., Kwon, H. M., Park, S. E., Park, C. Y., Lee, W. Y., Oh, K. W., & Rhee, E. J. (2025). Characteristics of Metabolic Dysfunction-Associated Steatotic Liver Disease and Its Risk for Hepatic Fibrosis in 476,124 Korean Adults: A Cross-Sectional Study. Endocrinology and Metabolism, 40(4), 648-652. https://doi.org/10.3803/enm.2024.2281
Vancouver
Lee DY, Ko JH, Jang HN, Moon SJ, Kwon HM, Park SE, et al. Characteristics of Metabolic Dysfunction-Associated Steatotic Liver Disease and Its Risk for Hepatic Fibrosis in 476,124 Korean Adults: A Cross-Sectional Study. Endocrinology and Metabolism. 2025;40(4):648-652. doi:10.3803/enm.2024.2281
BibTeX
@article{Lee2025,
author = {Lee, Da Yeon and Ko, Ji-Hee and Jang, Han-Na and Moon, Sun Joon and Kwon, Hye-Mi and Park, Se Eun and Park, Cheol-Young and Lee, Won-Young and Oh, Ki-Won and Rhee, Eun-Jung},
title = {Characteristics of Metabolic Dysfunction-Associated Steatotic Liver Disease and Its Risk for Hepatic Fibrosis in 476,124 Korean Adults: A Cross-Sectional Study},
journal = {Endocrinology and Metabolism},
year = {2025},
volume = {40},
number = {4},
pages = {648--652},
doi = {10.3803/enm.2024.2281}
}
EUVIMED